Published June 2016 | Version v1
Journal article Metadata-only

Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure

Creators

  • 1. Brachytherapy Department, MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Ul. Wybrzeze Armii Krajowej 15, 44-100 Gliwice (Poland)
  • 2. Radiotherapy and Brachytherapy Treatment Planning Department, MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Ul. Wybrzeze Armii Krajowej 15, 44-100 Gliwice (Poland)
  • 3. Radiotherapy Department, MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Ul. Wybrzeze Armii Krajowej 15, 44-100 Gliwice (Poland)
  • 4. III Department of Radiotherapy and Chemotherapy, MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Ul. Wybrzeze Armii Krajowej 15, 44-100 Gliwice (Poland)

Description

Background and purpose: To evaluate high-dose-rate brachytherapy (HDR BT) as a salvage modality for locally recurrent prostate cancer after primary radiotherapy failure.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2016.04.032

Additional details

Identifiers

DOI
10.1016/j.radonc.2016.04.032;
PII
S0167814016310787;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
119
Journal Issue
3
Journal Page Range
p. 405-410
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
50080956
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BRACHYTHERAPY; DOSE RATES; IMPLANTS; NEOPLASMS; PROSTATE
Descriptors DEC
BODY; DISEASES; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RADIOTHERAPY; THERAPY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.